EGFR and neoplasm: In the initial index patient’s tumor, WES analysis revealed amplification of chromosome 7 and deletion of chromosome 10 and focal deletion of CDKN2A locus on chromosome 9 along with an activating ectodomain EGFR A289V mutation, suggesting that the tumor cells had undergone chromothripsis.